118th Congress Health
S. 2044: End Price Gouging for Medications Act
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.
Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Peter Welch D-VTOriginal
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Jeff Merkley
- S. 1874: Title VIII Nursing Workforce Reauthorization Act of 2026
- S. 4259: Blue Skies for Taiwan Act of 2026
- S.J.Res. 196: Disapproval of Department of Education rule: Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations
- S.J.Res. 156: Disapproval of Bureau of Consumer Financial Protection relating to the withdrawal of the rule rule: Truth in Lending (Regulation Z); Consumer Credit Offered to Borrowers in Advance of Expected Receipt of Compensation for Work
- S. 1092: WIPPES Act
- S. 2110: REUSE Act of 2025
History
- Introduced in the Senate by Jeff Merkley.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.